New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider Pharmaceutical Investing
FDA Accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEKTOVI Pharmaceutical Investing
FDA Approves Merck's KEYTRUDA® in Combination With Padcev® for First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer Pharmaceutical Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy Pharmaceutical Investing
Jamieson Wellness Inc. Announces Filing of Management Information Circular for Annual and Special Meeting of Shareholders Life Science Investing News
Neoadjuvant Opdivo with Chemotherapy Demonstrates Long-Term, Durable Clinical Benefits for Patients with Resectable Non-Small Cell Lung Cancer at Three Years in the CheckMate -816 Trial Pharmaceutical Investing
BriaCell Announces Intention to Spin-Out Certain Pre-Clinical Assets into a Newly Created "SpinCo" Entity whereby Shareholders to Receive One New Share of "SpinCo" in Addition to Each Current Share of BriaCell Already Held Pharmaceutical Investing
